Market News AIOpen the app

BofA Securities is keeping a 'Hold' rating on Hims & Hers Health and has set a $21 price target.

OpinionRead the original at moomoo.com
Neutral

Hims & Hers received a reaffirmed Hold rating and a $21 price target from BofA. This is an analyst's view, not a reported change in the company's business, so its outlook stays unchanged.

HIMS · Hims & Hers Health, Inc.

AI read · Neutral

The AI's read

A rating is one firm's view, not a change to Hims & Hers' sales, costs, or products. The story gives no new company results or business developments, so a neutral reading fits.

Get alerts for HIMS

Follow Hims & Hers Health, Inc. (HIMS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HIMS
Free on the App Store and Google Play, or on the web.